Jennison Associates
PMVP icon

Jennison Associates’s PMV Pharmaceuticals PMVP Stock Holding History

Jennison Associates’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-303,641
Closed -$6.32M – 687
2022
Q1 		$6.32M Sell
303,641
-211,337
-41% -$3.73M ﹤0.01% 447
2021
Q4 		$11.9M Buy
514,978
+160,929
+45% +$3.89M 0.01% 428
2021
Q3 		$10.6M Sell
354,049
-4,103
-1% -$131K 0.01% 447
2021
Q2 		$12.2M Hold
358,152
– – 0.01% 437
2021
Q1 		$11.8M Buy
358,152
+209,558
+141% +$8.26M 0.01% 412
2020
Q4 		$9.14M Sell
148,594
-1,406
-0.9% -$55.2K 0.01% 416
2020
Q3 		$5.33M Buy
+150,000
New +$5.52M ﹤0.01% 431

Other funds holding PMVP

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Jennison Associates's PMVP Position: Q2 2022 in Review

Jennison Associates sold out of PMV Pharmaceuticals (PMVP) in Q2 2022, closing a stake of 303,641 shares — an estimated $6.32M sold.

Jennison Associates first reported a position in PMVP in Q3 2020 and held it in 7 quarters. The position peaked at $12.2M in Q2 2021. 105 funds tracked by Wall St. Rank hold PMVP as of Q2 2022.

  • Jennison Associates reported no remaining PMV Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • Jennison Associates sold 303,641 PMV Pharmaceuticals shares in Q2 2022, an estimated $6.32M.
  • Jennison Associates first reported a position in PMV Pharmaceuticals in Q3 2020 and held it in 7 quarters.
  • Jennison Associates's PMV Pharmaceuticals position peaked at $12.2M in Q2 2021.
  • 105 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q2 2022.

Based on Jennison Associates's 13F filing for Q2 2022, filed 2 Aug 2022.